Spearhead Capital Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,198
| Closed | -$256K | – | 207 |
|
|
2022
Q1 | $256K | Sell |
2,198
-2,423
| -52% | -$282K | 0.03% | 161 |
|
|
2021
Q4 | $696K | Buy |
4,621
+35
| +0.8% | +$5.27K | 0.08% | 78 |
|
|
2021
Q3 | $547K | Sell |
4,586
-16
| -0.3% | -$1.91K | 0.07% | 87 |
|
|
2021
Q2 | $448K | Buy |
4,602
+567
| +14% | +$55.2K | 0.06% | 127 |
|
|
2021
Q1 | $356K | Buy |
4,035
+795
| +25% | +$70.1K | 0.05% | 118 |
|
|
2020
Q4 | $310K | Buy |
3,240
+147
| +5% | +$14.1K | 0.05% | 138 |
|
|
2020
Q3 | $351K | Buy |
3,093
+179
| +6% | +$20.3K | 0.07% | 110 |
|
|
2020
Q2 | $288K | Buy |
+2,914
| New | +$288K | 0.06% | 110 |
|